Skip to Main Content

Paper Details

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.
Cancer Immunol Immunother
73
2014
CD4EM, CD8, CTLA-4, CTLA-4(NEG) Tregs, PD-1, PD-1(+)Tim-3(NEG)CD4EM, PD-1(NEG)Tim-3(+)CD8 (, PROSTVAC, PSA, Peripheral blood mononuclear cells, T cells, Tim, Tim-3, Tim-3(+), Tim-3(+) natural killer cells, immune cell subset, immune cell subsets, ipilimumab, metastatic castration-resistant prostate cancer, myeloid-derived suppressor cells, natural killer cells, patients, prostate-specific antigen, regulatory T cells, transgenes

Datasets